A commentary on 'Comparison of efficacy and safety between neoadjuvant chemotherapy and neoadjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis'

被引:0
|
作者
Qiao, Letian [1 ]
Liu, Yuan [1 ]
Ge, Dahe [2 ,4 ]
Jiang, Shuang [3 ]
机构
[1] First Peoples Hosp Shangqiu, Dept Pharm, Henan, Peoples R China
[2] First Peoples Hosp Shangqiu, Dept Gastroenterol, Henan, Peoples R China
[3] First Peoples Hosp Shangqiu, Dept Emergency, Intens Care Unit, Henan, Peoples R China
[4] First Peoples Hosp Shangqiu, Henan 476100, Peoples R China
关键词
D O I
10.1097/JS9.0000000000001211
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:3118 / 3119
页数:2
相关论文
共 50 条
  • [21] Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemotherapy or Tyrosine Kinase Inhibitors in Advanced Endometrial Cancer: A Systematic Review and Meta-Analysis
    Li, Yuting
    Li, Shixiu
    Liang, Juan
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2024,
  • [22] Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review
    Tian, Chunhong
    Yu, Yifan
    Wang, Yuqing
    Yang, Lunwei
    Tang, Ying
    Yu, Chengyang
    Feng, Gaofei
    Zheng, Dayong
    Wang, Xiongwen
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [24] A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).
    Li, Zhao
    Xu, Peng-Fei
    Mao, Wei-Min
    Kuang, YuKang
    Fan, Hai-Yin
    Zou, Bin
    Zhu, Jian-Feng
    Li, Chao
    Cheng, Xiao-Liang
    Liu, Xing-Fei
    Guo, Changying
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16038 - E16038
  • [25] Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
    Kong, Yue
    Su, Miaoyi
    Fang, Jun
    Chen, Mengyuan
    Zheng, Chao
    Jiang, Youhua
    Tao, Kaiyi
    Wang, Changchun
    Qiu, Guoqin
    Ji, Yongling
    Wang, Yuezhen
    Yang, Yang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Radiotherapy for Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Combined with Chemotherapy
    Kong, Y.
    Ji, Y.
    Qiu, G.
    Wang, Y.
    Fang, J.
    Chen, M.
    Chen, Q.
    Jiang, Y.
    Yang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E309 - E310
  • [27] The efficacy of neoadjuvant immune checkpoint inhibitors in lung squamous cell carcinoma and adenocarcinoma: a systematic review and single-arm meta-analysis
    Dong, Junguo
    Wang, Qixia
    Wang, Runchen
    Ye, Kaiwen
    Ye, Zhiming
    Lin, Jiayu
    Liang, Hengrui
    Wang, Wei
    JOURNAL OF THORACIC DISEASE, 2024, 16 (10)
  • [28] Efficacy and Safety of Neoadjuvant Immunotherapy Combined with Chemoradiotherapy vs. Combined with Chemotherapy in Esophageal Cancer: A Systematic Review and Meta-Analysis
    Liu, Y.
    Bao, Y.
    Men, Y.
    Wang, Y.
    Hui, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E163 - E164
  • [29] Comparison of efficacy and safety of neoadjuvant regimens for resectable esophageal squamous cell carcinoma: A meta-analysis
    Wang, Ting
    Cai, Liyu
    Guo, Zefeng
    You, Peimeng
    Liu, Shengbo
    Qiu, Hongrui
    Li, Hao
    Wu, Shaowei
    Zhou, Haiyu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Efficacy and safety of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for locally advanced stages of esophageal cancer: A systematic review and meta-analysis
    Wu, Jing
    Deng, Rong
    Ni, Tingting
    Zhong, Qin
    Tang, Fei
    Li, Yan
    Zhang, Yu
    FRONTIERS IN ONCOLOGY, 2022, 12